Jason N. Butler

Citizens

Jason N. Butler is an analyst from Citizens Ranked #1773 out of 4620 analysts, they have issued 20 stock ratings with a success rate of 72.73% and an average return of 24.15%.

Jason N. Butler has a well-established track record, with 20 ratings issued in the market sector. They have consistently delivered a success rate of 72.73% and an average return of 24.15%, underscoring their expertise and ability to identify winning opportunities for investors.

#1773

Out of 4620

20

Total Ratings

+72.73%

Success Rate

+24.15%

Average Return

Recent Ratings Analysis

NERV

Apr 15, 2026

Target

$14.00

Current

$5.87

Performance

—

Jason N. Butler rated NERV as Market Outperform on Apr 15, 2026, setting a price target of 14. Shares have remained stable near 5.87, leaving the 14 target still in play.

PGEN

Mar 26, 2026

Target

$9.00

Current

$3.98

Performance

—

On Mar 26, 2026, PGEN was given a Market Outperform rating by Jason N. Butler, with a target price of 9. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

NSRX

Mar 26, 2026

Target

$18.00

Current

$2.25

Performance

—

NSRX received a Market Outperform rating from Jason N. Butler on Mar 26, 2026, aiming for 18. Price action was muted, as shares hovered around 2.25 despite the bullish outlook.

ESPR

Mar 13, 2026

Target

$5.00

Current

$2.05

Performance

-15.98%

On Mar 13, 2026, Jason N. Butler published a Market Outperform outlook on ESPR, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 2.05.

GHRS

Mar 06, 2026

Target

$42.00

Current

$16.77

Performance

5.27%

Jason N. Butler on Mar 06, 2026 assigned GHRS a Market Outperform rating, with a price target of 42. The Buy call aligned well with market performance, producing a gain of 5.27%.

ARGX

Feb 27, 2026

Target

$944.00

Current

$828.35

Performance

8.01%

On Feb 27, 2026, Jason N. Butler reaffirmed ARGX with a Market Outperform rating, targeting 944. The recommendation was supported by strong follow-through as the stock rose from 828.35 to 828.35.

IRWD

Feb 26, 2026

Target

$10.00

Current

$4.04

Performance

10.38%

IRWD was rated Market Outperform by Jason N. Butler on Feb 26, 2026, with a price objective of 10. A bullish response from the market helped close the gap of 5.96 to the target.

ACAD

Feb 26, 2026

Target

$35.00

Current

$22.02

Performance

-10.63%

On Feb 26, 2026, Jason N. Butler initiated coverage on ACAD with a Market Outperform rating and target of 35. The Buy call has yet to be validated as shares remain 12.98 away from the target.

ACHV

Nov 25, 2025

Target

$19.00

Current

$3.61

Performance

-21.35%

Jason N. Butler issued a Market Outperform recommendation for ACHV on Nov 25, 2025, price target set at 19. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

RAPP

Nov 07, 2025

Target

$80.00

Current

$36.15

Performance

40.88%

On Nov 07, 2025, RAPP was evaluated by Jason N. Butler, who gave a Market Outperform rating and target of 80. This case illustrates how a timely bullish rating can translate into tangible gains of 40.88%.

WULF

Oct 29, 2025

Target

$22.00

Current

$20.95

Performance

44.48%

Jason N. Butler rated WULF as Market Outperform on Oct 29, 2025, setting a price target of 22. The call has proven timely, with shares rising 44.48% toward the price target of 22.

RZLT

Oct 29, 2025

Target

$17.00

Current

$3.55

Performance

-62.75%

On Oct 29, 2025, RZLT was given a Market Outperform rating by Jason N. Butler, with a target price of 17. Despite the Buy call, shares fell from 3.55 to 3.55, challenging the optimistic stance.

ABVX

Sep 25, 2025

Target

$114.00

Current

$125.80

Performance

53.41%

ABVX received a Market Outperform rating from Jason N. Butler on Sep 25, 2025, aiming for 114. Momentum has favored the Buy call, with shares climbing from 125.8 to 125.8, rewarding those who trusted the recommendation.

CRMD

Sep 09, 2025

Target

$22.00

Current

$7.30

Performance

-43.98%

On Sep 09, 2025, Jason N. Butler published a Market Outperform outlook on CRMD, with a target of 22. Market action contradicted the Buy thesis, as shares slipped to 7.3.

CYTK

Sep 02, 2025

Target

$78.00

Current

$66.35

Performance

33.72%

Jason N. Butler on Sep 02, 2025 assigned CYTK a Market Outperform rating, with a price target of 78. The Buy call aligned well with market performance, producing a gain of 33.72%.

ZVRA

Aug 13, 2025

Target

$18.00

Current

$9.79

Performance

3.82%

On Aug 13, 2025, Jason N. Butler reaffirmed ZVRA with a Market Outperform rating, targeting 18. Market indecision has kept the 18 target in a holding pattern.

HALO

Aug 06, 2025

Target

$91.00

Current

$67.31

Performance

8.01%

HALO was rated Market Outperform by Jason N. Butler on Aug 06, 2025, with a price objective of 91. A bullish response from the market helped close the gap of 23.69 to the target.

Frequency Asked Questions

Who is Jason N. Butler?

Jason N. Butler is an analyst from Citizens.

What is Jason N. Butler's success rate?

Jason N. Butler currently has a success rate of +72.73%.

How many ratings has Jason N. Butler issued?

Jason N. Butler has issued 20 stock ratings so far.

What is the average return of Jason N. Butler's calls?

Their stock ratings have generated an average return of +24.15%.

What is Jason N. Butler's ranking?

Jason N. Butler is ranked #1773 out of 4620 analysts.

What types of ratings does Jason N. Butler give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Jason N. Butler?

You can follow Jason N. Butler by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Jason N. Butler?

Their latest rating was a Buy on NERV issued on 2026-04-15.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep